wyszukanych pozycji: 3
Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
ISBN: 9781461436812 / Angielski / Miękka / 2012 / 82 str. Termin realizacji zamówienia: ok. 20 dni roboczych. This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These apply particularly to evaluations that focus on outputs such as regulatory approval, or the commercial impact of product labeling on the sales forecast over a limited timeframe. The Brief also provides an overview of intellectual property assessment that can impact a product's lifespan on the market...
This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview...
|
|
cena:
231,29 zł |
Muscular Dystrophy: A Concise Guide
ISBN: 9783319173610 / Angielski / Miękka / 2015 / 191 str. Termin realizacji zamówienia: ok. 20 dni roboczych. This practical and concise guide offers an overview of muscular dystrophy's complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives... This practical and concise guide offers an overview of muscular dystrophy's complicated features, treatment options and general resources. New trea... |
|
cena:
192,74 zł |
Rare Disease Drug Development: Clinical, Scientific, Patient, and Caregiver Perspectives
ISBN: 9783030786076 / Angielski / Miękka / 2022 Termin realizacji zamówienia: ok. 20 dni roboczych. This book provides a broad overview of rare disease drug development. It offers unique insights from various perspectives, including third-party capital providers, caregivers, patient advocacy groups, drug development professionals, marketing and commercial experts, and patients. A unique reference, the book begins with narratives on the many challenges faced by rare disease patient and their caregivers. Subsequent chapters underscore the critical, multidimensional role of patient advocacy groups and the novel approaches to related clinical trials, investment decisions, and... This book provides a broad overview of rare disease drug development. It offers unique insights from various perspectives, including third-party ca... |
|
cena:
154,18 zł |